FitLife Brands ROE 2010-2025 | FTLF
Current and historical return on equity (ROE) values for FitLife Brands (FTLF) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| FitLife Brands ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.01B | $0.04B | 25.53% |
| 2024-12-31 | $0.01B | $0.04B | 27.48% |
| 2024-09-30 | $0.01B | $0.03B | 26.23% |
| 2024-06-30 | $0.01B | $0.03B | 28.32% |
| 2024-03-31 | $0.01B | $0.03B | 26.67% |
| 2023-12-31 | $0.01B | $0.03B | 20.41% |
| 2023-09-30 | $0.00B | $0.03B | 17.39% |
| 2023-06-30 | $0.00B | $0.02B | 13.48% |
| 2023-03-31 | $0.00B | $0.02B | 9.41% |
| 2022-12-31 | $0.00B | $0.02B | 14.63% |
| 2022-09-30 | $0.00B | $0.02B | 20.51% |
| 2022-06-30 | $0.00B | $0.02B | 22.22% |
| 2022-03-31 | $0.01B | $0.02B | 29.85% |
| 2021-12-31 | $0.01B | $0.02B | 32.26% |
| 2021-09-30 | $0.01B | $0.02B | 70.18% |
| 2021-06-30 | $0.01B | $0.02B | 93.62% |
| 2021-03-31 | $0.01B | $0.01B | 97.30% |
| 2020-12-31 | $0.01B | $0.01B | 128.57% |
| 2020-09-30 | $0.00B | $0.01B | 63.16% |
| 2020-06-30 | $0.00B | $0.01B | 47.06% |
| 2020-03-31 | $0.00B | $0.01B | 75.00% |
| 2019-12-31 | $0.00B | $0.00B | 80.00% |
| 2019-09-30 | $0.00B | $0.00B | 85.71% |
| 2019-06-30 | $0.00B | $0.00B | 66.67% |
| 2019-03-31 | $0.00B | $0.00B | 44.44% |
| 2018-12-31 | $0.00B | $0.00B | 0.00% |
| 2018-09-30 | $-0.01B | $0.00B | -640.00% |
| 2018-06-30 | $-0.01B | $0.00B | -300.00% |
| 2018-03-31 | $-0.01B | $0.00B | -190.48% |
| 2017-12-31 | $-0.01B | $0.00B | -133.33% |
| 2017-09-30 | $0.00B | $0.01B | -30.00% |
| 2017-06-30 | $0.00B | $0.01B | -18.60% |
| 2017-03-31 | $0.00B | $0.01B | 0.00% |
| 2016-12-31 | $0.00B | $0.01B | 8.70% |
| 2016-09-30 | $0.00B | $0.01B | 0.00% |
| 2016-06-30 | $0.00B | $0.01B | 0.00% |
| 2016-03-31 | $0.00B | $0.01B | -11.43% |
| 2015-12-31 | $0.00B | $0.01B | -25.81% |
| 2015-09-30 | $0.00B | $0.01B | -14.29% |
| 2015-06-30 | $0.00B | $0.01B | 0.00% |
| 2015-03-31 | $0.00B | $0.01B | 14.29% |
| 2014-12-31 | $0.00B | $0.01B | 29.63% |
| 2014-09-30 | $0.00B | $0.01B | 48.00% |
| 2014-06-30 | $0.00B | $0.01B | 34.78% |
| 2014-03-31 | $0.00B | $0.01B | 17.39% |
| 2013-12-31 | $0.00B | $0.01B | 16.67% |
| 2013-09-30 | $0.00B | $0.01B | 32.00% |
| 2013-06-30 | $0.00B | $0.01B | 32.00% |
| 2013-03-31 | $0.00B | $0.01B | 52.17% |
| 2012-12-31 | $0.00B | $0.01B | 60.00% |
| 2012-09-30 | $0.00B | $0.01B | 47.06% |
| 2012-06-30 | $0.00B | $0.01B | 50.00% |
| 2012-03-31 | $0.00B | $0.00B | 28.57% |
| 2011-12-31 | $0.00B | $0.00B | 0.00% |
| 2011-09-30 | $0.00B | $0.00B | -61.54% |
| 2011-06-30 | $0.00B | $0.00B | -133.33% |
| 2011-03-31 | $0.00B | $0.00B | -200.00% |
| 2010-12-31 | $0.00B | $0.00B | -533.33% |
| 2010-09-30 | $-0.01B | 0.00% | |
| 2010-06-30 | $-0.01B | 0.00% | |
| 2010-03-31 | $-0.01B | 0.00% | |
| 2009-12-31 | $-0.01B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.133B | $0.064B |
| FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |